COUGHLIN TIMOTHY (CIK 1376043) reported 13 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-16). Recent activity: Buy TVTX (10,000 shares), Sell TVTX (10,000 shares), Buy VIR (8,000 shares), Buy VIR (8,000 shares), Buy ADCT (45,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 10,000 | $265,200 |
| 2026-06-16 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 10,000 | $500,747 |
| 2026-06-10 | Vir Biotechnology, Inc. (VIR) | Director | Buy | 8,000 | $0 |
| 2026-06-10 | Vir Biotechnology, Inc. (VIR) | Director | Buy | 8,000 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Buy | 45,000 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Sell | 12,600 | $38,808 |
| 2026-05-21 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,000 | $0 |
| 2026-05-19 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 3,250 | $141,342 |
| 2025-11-04 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 8,000 | $130,640 |
| 2025-11-04 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 10,000 | $174,400 |
| 2025-11-04 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 18,000 | $630,540 |
| 2025-06-05 | ADC Therapeutics SA (ADCT) | Director | Buy | 40,000 | $0 |
| 2025-05-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 6,500 | $0 |
Source: SEC Form 4 filings · as of 2026-06-16